{"name":"LeonaBio","slug":"leonabio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":70682000,"netIncome":-96940000,"cash":58779000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ATH-1020","genericName":"ATH-1020","slug":"ath-1020","indication":"Other","status":"phase_1"},{"name":"ATH-1105","genericName":"ATH-1105","slug":"ath-1105","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ATH-1020","genericName":"ATH-1020","slug":"ath-1020","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ATH-1105","genericName":"ATH-1105","slug":"ath-1105","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPNzFuXzhTZ05VbXNDVE5hZWlZV0pudHRodjVhNG9OdWE0aEg4aTRCQWtiSXpkX0NqR2hOQXFCUy12blotdDU0LXQwMUpzcmJ1T2FwS3FMeGNuSTJ3eGFjMkVKRnJqU3BrQUhyQzFxYmRxQlpIYWlPU1BFeDNCLVdsQUF3V010YzdoSkVIeHljU1dEVWJIcVV1bQ?oc=5","date":"2026-04-02","type":"pipeline","source":"Stock Titan","summary":"[EFFECT] LeonaBio, Inc. SEC Filing - Stock Titan","headline":"[EFFECT] LeonaBio, Inc. SEC Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOa0lLV3hPaklOWjNJNFp2N1QtdklBR2JZR0cwMXE2d2dSRVVpaFp6Z1daajhsRzlPR2VNOFBaQXlVejBpSWRrVEpoNzdhVHFWMVZaMzhSTXk3blZyRmY3aDRud2hjNmdoTkUxY2oxaFVZeDNRTnFpc3V2eDJLYzMwWFo2Qm5zTElITXlOcWRxVkFfZXg2RXN5bHJ3ZDdZLWlFNjUwelJZNkYxVFR1WVJR?oc=5","date":"2026-03-31","type":"trial","source":"Stock Titan","summary":"LeonaBio (NASDAQ: ATHA) expands Sermonix deal disclosure and ELAINE-3 trial spend - Stock Titan","headline":"LeonaBio (NASDAQ: ATHA) expands Sermonix deal disclosure and ELAINE-3 trial spend","sentiment":"neutral"},{"date":"2026-03-31","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNbzJxU1RJckN1ZDRSNFFrOEpnUWZZQzJ5X0Uxc3F2cTJTRjBwYklxX2NzNFR6eXlhVzN0NlNpcU9uU2NYME1pRmhfRDgzOFQyZ2hIbzM1VXFhdFFfZV9PYzhKSTlqd2JxTWx0MkE3ODhyZEliSWtLR3lGaGlHLXlxUS1sVnRnVXo4Q0JlWjVpQjNNQWxmVzByUTNYNlZiVEhTWmp1alpIM1ZKdnppVlMxZ3A4MlFrUEJBcGhUdWx5QTNNcndxTmFkY0tldDNpMGFYdXh1OGNqY3hRVlVjemJpWFhYc3E?oc=5","date":"2026-03-26","type":"pipeline","source":"GlobeNewswire","summary":"LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewswire","headline":"LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update","sentiment":"neutral"},{"date":"2026-03-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQnlUdEtFRG43V2poRlRSV3d4NU5RLVh6cWxwb3dQaHFwUjU4TTlhblRVaDVZV1RHRjM5WDc0cGUySzBkZkk4dXE5ZGJ6WlJIa0dWcGJicjVLOGJlQ0xETW1oLW1vNmhEWlo1VmstZTRZMkhWSjRJTEVPelRsWUFNTlE5RENxeGZOdWhzNDVyd1E1eE5KclVqeGN2QWZoR3ZYdER6bEZuWXVKN0E?oc=5","date":"2026-03-10","type":"pipeline","source":"Stock Titan","summary":"[DEFR14A] LeonaBio, Inc. Revised Proxy Statement - Stock Titan","headline":"[DEFR14A] LeonaBio, Inc. Revised Proxy Statement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNQjNRdGU1UFVxLU5OMTRCekVtclNNU094eFFuN3pXNnd6RlJGbWVJOHFyREpYcFUyeTVuWFBGWFJ5LXlCSXpGN0NBUEtRaEtxMVdfQU43V2dkWHc4WHJMSjZ5OS1vS0dPY09uYnE0YnR3SmZkMGtkZkpJNzYyRThpM0tGR3lqN3ZmNUtHbg?oc=5","date":"2026-01-09","type":"pipeline","source":"Fierce Pharma","summary":"Athira Pharma roars into the new year with rebrand to LeonaBio - Fierce Pharma","headline":"Athira Pharma roars into the new year with rebrand to LeonaBio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNSXlqYmRiRWFnNGxkbXVOc2hNUmtKTTI5cmhBQm1EbnRWRTNLbV9rUktWZXFHWU1PQ2Z6Qmd6a0c0Y2lXaWVEek83SGRfSzZnS1FqTUk3MnRGQ1ZzQWZKSkxXQzQtc245YXZXVmROanN5WFFoS1J5MWdEMksyZFlKcmNSRnphMTRH?oc=5","date":"2026-01-09","type":"pipeline","source":"Yahoo Finance","summary":"Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA” - Yahoo Finance","headline":"Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":70682000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-96940000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":58779000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}